Michel Ledizet
Principal investigator.
Medtech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2015First federal award
$8.8MFederal grants as PI14 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
14 awards · $8.8M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| May 11, 2022 | NIH | SBIR Phase II An antigen-detection assay to diagnose Babesia microti infection | $692K | L2 DIAGNOSTICS LLC |
| May 21, 2021 | NIH | STTR Phase I Vaccination against Zika virus infection using mosquito NeSt1 protein | $294K | L2 DIAGNOSTICS LLC |
| May 10, 2021 | NIH | SBIR Phase II An antigen-detection assay to diagnose Babesia microti infection | $692K | L2 DIAGNOSTICS LLC |
| Jun 22, 2020 | NIH | SBIR Phase II An antigen-detection assay to diagnose Babesia microti infection | $692K | L2 DIAGNOSTICS LLC |
| Jun 22, 2020 | NIH | SBIR Phase II An antigen-detection assay to diagnose Babesia microti infection | $2.1M | L2 DIAGNOSTICS LLC |
| Jun 16, 2020 | NIH | STTR Phase I Vaccination against Zika virus infection using mosquito NeSt1 protein | $299K | L2 DIAGNOSTICS LLC |
| Jul 27, 2018 | NIH | STTR Phase I Validation of a Diagnostic Test for Borrelia miyamotoi | $274K | L2 DIAGNOSTICS LLC |
| Jan 10, 2018 | NIH | SBIR Phase I An antigen-detection assay to diagnose Babesia microti infection | $300K | L2 DIAGNOSTICS LLC |
| Jan 9, 2018 | NIH | SBIR Phase I An antigen-detection assay to diagnose Babesia microti infection | $300K | L2 DIAGNOSTICS LLC |
| Aug 14, 2017 | NIH | STTR Phase I Validation of a Diagnostic Test for Borrelia miyamotoi | $300K | L2 DIAGNOSTICS LLC |
| Jun 20, 2016 | NIH | SBIR Phase II A serologic assay to measure successful Lyme borreliosis antibiotic therapy | $880K | L2 DIAGNOSTICS LLC |
| Jun 24, 2015 | NIH | SBIR Phase II Diagnostic Assays for early Lyme Borreliosis using in-vivo expressed antigens | $826K | L2 DIAGNOSTICS LLC |
| Jun 17, 2015 | NIH | STTR Phase I RNA Detection as an Improved Diagnostic Assay for Human Leptospirosis | $300K | L2 DIAGNOSTICS LLC |
| Jun 11, 2015 | NIH | SBIR Phase II A serologic assay to measure successful Lyme borreliosis antibiotic therapy | $880K | L2 DIAGNOSTICS LLC |
Peer ranks
Federal funding#97
Awards as PI#65
Patents#505
Companies
- L2 DIAGNOSTICS LLCLinked by awards · Medtech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.